Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    WFP warns funding gaps will leave millions hungry in 2027

    November 21, 2026

    Chip boom lifts South Korea into $1 trillion export club

    November 21, 2026
    Facebook X (Twitter) Instagram
    • Home
    • Contact Us
    Africa ForceAfrica Force
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Africa ForceAfrica Force
    Home » Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa
    ACCESS Newswire

    Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa

    September 25, 2024
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    NEW YORK, NY / ACCESSWIRE / September 25, 2024 / The Africa Centres for Disease Control and Prevention (Africa CDC) and IAVI, a nonprofit scientific research organization, have signed a Memorandum of Understanding (MoU) to enhance the continent’s disease-fighting capacity, pandemic readiness, and supply resilience by expanding capabilities for locally driven research, development, manufacturing, and supply of priority vaccines and antibodies and to strengthen Africa CDC-led initiatives with expert support and shared resources.

    The new partnership brings together IAVI’s expertise in vaccine and antibody development and access and the extensive network and expertise of Africa CDC to tackle urgent public health challenges and promote long-term health security. Key initiatives under this MoU include supporting the development of vaccines and antibodies for regional health priorities, such as Lassa fever and HIV; fostering a sustainable supply and demand ecosystem for priority products including monoclonal antibodies in the region; strengthening African research and development capacity; and exploring regional stockpile strategies for licensed and investigational products to ensure rapid responses during health crises.

    “This cooperation is a key step in IAVI’s mission to improve global access to biomedical innovations and safeguard public health. It goes beyond R&D; it’s about creating a vibrant health innovation ecosystem that meets current and future needs across Africa,” said Mark Feinberg, M.D., Ph.D., IAVI president and CEO.

    The MoU exemplifies the action-oriented partnerships called for under the New Public Health Order, driving forward the continent’s vision for redefining global health architecture, and making Africa and the world better prepared for future health threats.

    These initiatives can be advanced thanks to IAVI’s funders and in collaboration with IAVI partners, including Wellcome, the Coalition for Epidemic Preparedness Innovations (CEPI), the European and Developing Countries Clinical Trials Partnership (EDCTP), and the U.S. Agency for International Development (USAID) and U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the Accelerate the Development of Vaccines and New Technologies to Combat the AIDS Epidemic (ADVANCE) program.

    ** ENDS **

    About IAVI

    IAVI is a non-profit scientific research organization dedicated to addressing global, unmet health challenges including HIV, tuberculosis, and a range of emerging infectious diseases. Its mission is to translate scientific discoveries into affordable, globally accessible public health tools. Read more at iavi.org.

    IAVI Media Contact

    Ethel Makila
    Director, Communications, Advocacy, and Policy
    +254 71 904 3142
    EMakila@iavi.org

    SOURCE: IAVI

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Global Scams Remain Widespread: Nearly Two in Three Adults Worldwide Report Scam Encounters, 9% Lost Money

    November 19, 2026

    OMP Extends UnisonIQ with Agent Library and Agent Studio: AI Agents that Produce Executable Supply Chain Plans

    November 3, 2026

    Chervon Names Jody Grimsley Senior National Account Manager

    November 2, 2026

    IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development

    October 28, 2026
    Latest News

    Guinea ends mpox outbreak more than two years after first case

    WFP warns funding gaps will leave millions hungry in 2027

    Chip boom lifts South Korea into $1 trillion export club

    Air Arabia Egypt launches Cairo to Al Ain flights soon

    Botswana reviews proposed 33% power tariff hike today

    PM Modi meets Prince and Princess of Wales for climate talks

    © 2026 Africa Force | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.